Published in J Immunol on October 01, 1983
HLA-DR alleles differ in their ability to present staphylococcal enterotoxins to T cells. J Exp Med (1990) 2.30
Membrane biogenesis during B cell differentiation: most endoplasmic reticulum proteins are expressed coordinately. J Cell Biol (1990) 1.74
Identification of the tyrosine phosphatase PTP1C as a B cell antigen receptor-associated protein involved in the regulation of B cell signaling. J Exp Med (1995) 1.73
Immunodominance of major histocompatibility complex class I-restricted influenza virus epitopes can be influenced by the T-cell receptor repertoire. J Virol (1995) 1.71
Induced differentiation of a transformed clone of Ly-1+ B cells by clonal T cells and antigen. Proc Natl Acad Sci U S A (1986) 1.46
Development of B-1 cells: segregation of phosphatidyl choline-specific B cells to the B-1 population occurs after immunoglobulin gene expression. J Exp Med (1994) 1.40
Demonstration of a B-lymphocyte mitogen produced by the Lyme disease pathogen, Borrelia burgdorferi. Infect Immun (1992) 1.33
The open reading frames in the 3' long terminal repeats of several mouse mammary tumor virus integrants encode V beta 3-specific superantigens. J Exp Med (1992) 1.30
Fibroblasts can induce thymocyte positive selection in vivo. Proc Natl Acad Sci U S A (1993) 1.14
T cell positive selection by a high density, low affinity ligand. Proc Natl Acad Sci U S A (1998) 1.12
The aryl hydrocarbon receptor interacts with ATP5α1, a subunit of the ATP synthase complex, and modulates mitochondrial function. Toxicol Appl Pharmacol (2011) 1.02
Cross-reactive idiotypes and common antigen binding specificities expressed by a series of murine B-cell lymphomas: etiological implications. Proc Natl Acad Sci U S A (1985) 1.01
Two separate functions of class II (Ia) molecules: T-cell stimulation and B-cell excitation. Proc Natl Acad Sci U S A (1985) 0.99
Diverse chemicals including aryl hydrocarbon receptor ligands modulate transcriptional activity of the 3'immunoglobulin heavy chain regulatory region. Toxicology (2009) 0.94
Role of cell surface immunoglobulin in B-lymphocyte activation. Proc Natl Acad Sci U S A (1984) 0.92
Proteolytic processing is required for viral superantigen activity. J Exp Med (1995) 0.89
2,3,7,8-tetrachlorodibenzo-p-dioxin induces transcriptional activity of the human polymorphic hs1,2 enhancer of the 3'Igh regulatory region. J Immunol (2012) 0.86
Tumorigenesis mediated by an antigen receptor. Proc Natl Acad Sci U S A (1992) 0.85
Mouse transplant models for evaluating the oncogenic risk of a self-inactivating XSCID lentiviral vector. PLoS One (2013) 0.85
Cytokine-induced differentiation of IgA B cells: studies using an IgA expressing B-cell lymphoma. Immunology (1992) 0.81
Expression of intracisternal A-type particles is increased when a B-cell lymphoma differentiates into an immunoglobulin-secreting cell. J Virol (1989) 0.81
A dioxin response element in the multiple cloning site of the pGL3 luciferase reporter influences transcriptional activity. Toxicol In Vitro (2012) 0.77
The aryl hydrocarbon receptor regulates an essential transcriptional element in the immunoglobulin heavy chain gene. Cell Immunol (2015) 0.76
The AhR and NF-κB/Rel Proteins Mediate the Inhibitory Effect of 2,3,7,8-Tetrachlorodibenzo-p-Dioxin on the 3' Immunoglobulin Heavy Chain Regulatory Region. Toxicol Sci (2015) 0.75
Cyclosporine inhibition of a murine B cell lymphoma. Clin Exp Immunol (1986) 0.75
Asbestos activates CH12.LX B-lymphocytes via macrophage signaling. J Immunotoxicol (2011) 0.75
Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10. Eur J Immunol (1992) 3.39
The CH series of murine B cell lymphomas: neoplastic analogues of Ly-1+ normal B cells. Immunol Rev (1986) 1.81
Restricted Ig variable region gene expression among Ly-1+ B cell lymphomas. J Immunol (1988) 1.72
Variation of antigenic characteristics between different mouse lymphomas induced by the Moloney virus. J Natl Cancer Inst (1966) 1.61
Frequent aberrant immunoglobulin gene rearrangements in pro-B cells revealed by a bcl-xL transgene. Immunity (1996) 1.54
Biased immunoglobulin variable region gene expression by Ly-1 B cells due to clonal selection. Eur J Immunol (1989) 1.52
Induced differentiation of a transformed clone of Ly-1+ B cells by clonal T cells and antigen. Proc Natl Acad Sci U S A (1986) 1.46
Phosphatidyl choline is recognized by a series of Ly-1+ murine B cell lymphomas specific for erythrocyte membranes. J Exp Med (1986) 1.43
High frequency expression of S107 VH genes by peritoneal B cells of B10.H-2aH-4bP/WTS mice. J Immunol (1990) 1.43
Development of B-1 cells: segregation of phosphatidyl choline-specific B cells to the B-1 population occurs after immunoglobulin gene expression. J Exp Med (1994) 1.40
Lymphoma models for B cell activation and tolerance. III. Cell cycle dependence for negative signalling of WEHI-231 B lymphoma cells by anti-mu. J Exp Med (1986) 1.33
Dextran sulphate: an adjuvant for cell-mediated immune responses. Immunology (1977) 1.33
B-1 cells are made, not born. Immunol Today (1993) 1.32
Novel type of murine B-cell lymphoma. Nature (1978) 1.29
Transplantable B-cell lymphomas in B10. H-2aH-4bp/Wts mice. Immunogenetics (1982) 1.23
Cytolysis of mouse lymph node cells by alloantibody: a comparison of guinea-pig and rabbit complements. Immunology (1969) 1.22
Restricted immunoglobulin variable region gene usage by normal Ly-1 (CD5+) B cells that recognize phosphatidyl choline. J Exp Med (1989) 1.20
Phagocyte-derived lactate stimulates oxygen consumption by Neisseria gonorrhoeae. An unrecognized aspect of the oxygen metabolism of phagocytosis. J Clin Invest (1988) 1.18
Antigen-induced murine B cell lymphomas. I. Induction and characterization of CH1 and CH2. J Immunol (1978) 1.11
B-1 cell development: evidence for an uncommitted immunoglobulin (Ig)M+ B cell precursor in B-1 cell differentiation. J Exp Med (1998) 1.06
Production, testing, and utility of double congenic strains of mice.I. B10 H-2aa=H-48P-wis and Bio-H-4BP-Wis. Transplantation (1974) 1.02
Phenotype of B cells responding to the thymus-independent type-2 antigen polyvinyl pyrrolidinone. Int Immunol (1996) 1.02
Antiphencyclidine monoclonal Fab fragments reverse phencyclidine-induced behavioral effects and ataxia in rats. J Pharmacol Exp Ther (1996) 1.01
Cross-reactive idiotypes and common antigen binding specificities expressed by a series of murine B-cell lymphomas: etiological implications. Proc Natl Acad Sci U S A (1985) 1.01
An epitope common to HLA class I and class II antigens, Ig light chains, and beta 2-microglobulin. Immunogenetics (1987) 1.01
The murine kappa light chain shift. Nature (1978) 1.01
Lymphoma models for B cell activation and tolerance. IV. Growth inhibition by anti-Ig of CH31 and CH33 B lymphoma cells. Eur J Immunol (1986) 1.00
Naturally occurring soluble H-2 specificity in mouse tissues. Immunology (1965) 1.00
Two separate functions of class II (Ia) molecules: T-cell stimulation and B-cell excitation. Proc Natl Acad Sci U S A (1985) 0.99
Transplantation antigen of mice: cellular localization of antigen determined by the H-2 locus. Transplantation (1966) 0.98
Antigen-induced murine B cell lymphomas. II. Exploitation of the surface idiotype as tumor specific antigen. J Immunol (1978) 0.97
Antigenic cross-reactivity between adenocarcinoma of the breast and fibrocystic disease of the breast. J Natl Cancer Inst (1976) 0.97
The male antigen. II. Regulation of the primary and secondary responses to H-Y by H-2 associated genes. Cell Immunol (1974) 0.97
Structure and expression of major histocompatibility complex-binding protein 2, a 275-kDa zinc finger protein that binds to an enhancer of major histocompatibility complex class I genes. Proc Natl Acad Sci U S A (1992) 0.95
Suppression or augmentation of the antihapten response in mice by antibodies of different specificities. J Exp Med (1973) 0.94
H-2 control of expression of an idiotype shared by normal B cells and a B-cell lymphoma. Immunogenetics (1985) 0.94
Anti-phencyclidine monoclonal Fab fragments markedly alter phencyclidine pharmacokinetics in rats. J Pharmacol Exp Ther (1994) 0.93
Specific immunosuppression by minute doses of passive antibody. II. The site of action. J Reticuloendothel Soc (1970) 0.93
Induced differentiation of a B cell lymphoma with known antigen specificity. J Mol Cell Immunol (1984) 0.92
Role of cell surface immunoglobulin in B-lymphocyte activation. Proc Natl Acad Sci U S A (1984) 0.92
A VH12 transgenic mouse exhibits defects in pre-B cell development and is unable to make IgM+ B cells. J Immunol (2001) 0.91
Immunosuppression by antilymphocyte serum and its effect on tumors indduced by 3-methylcholanthrene in mice. J Natl Cancer Inst (1971) 0.91
High-level secretion of two antibody single chain Fv fragments by Pichia pastoris. J Immunol Methods (1997) 0.90
Chromosome 15 trisomy in spontaneous and carcinogen-induced murine lymphomas of B-cell origin. Int J Cancer (1981) 0.90
Lymphoma growth in vivo: electronic discrimination between tumor and stroma cells. Science (1965) 0.89
Autoantibodies to phosphatidylcholine. The murine antibromelain RBC response. Ann N Y Acad Sci (1992) 0.89
Mechanism of B cell lymphoma immunotherapy with passive xenogeneic anti-idiotype serum. J Immunol (1980) 0.89
A role for oxidative stress in suppressing serum immunoglobulin levels in lead-exposed Fisher 344 rats. Arch Environ Contam Toxicol (2000) 0.88
Disrupted B-lymphocyte development and survival in interleukin-2-deficient mice. Immunology (2001) 0.87
Lymphoma models for B cell activation and tolerance. V. Anti-Ig mediated growth inhibition is reversed by phorbol myristate acetate but does not involve changes in cytosolic free calcium. J Mol Cell Immunol (1987) 0.87
Antigenic cross-reactivity between benign and malignant neoplasms of the human breast. J Natl Cancer Inst (1974) 0.86
An in vitro model for toxin-mediated vascular leak syndrome: ricin toxin A chain increases the permeability of human endothelial cell monolayers. Blood (1997) 0.86
Ig isotype switching in B lymphocytes. The effect of T cell-derived interleukins, cytokines, cholera toxin, and antigen on isotype switch frequency of a cloned B cell lymphoma. Int Immunol (1991) 0.86
Effects of chronic heparin administration on coronary vascular adaptation to hypertension and ventricular hypertrophy in sheep. Circulation (1999) 0.85
Specific immunosuppression by passive antibody. V. Participation of macrophages in reversal of suppression by peritoneal exudate cells from immune animals. Cell Immunol (1974) 0.84
Ig isotype switching in B lymphocytes. Isolation and characterization of clonal variants of the murine Ly-1+ B cell lymphoma, CH12, expressing isotypes other than IgM. J Immunol (1988) 0.84
Specific immunosuppression by minute doses of passive antibody. Transplant Proc (1969) 0.84
Specific immunosuppression by minute doses of passive antibody. 3. Reversal of suppression by peritoneal exudate cells from immune animals. Cell Immunol (1971) 0.83
Mechanisms that limit the diversity of antibody: three sequentially acting mechanisms that favor the spontaneous production of germline encoded anti-phosphatidyl choline. Int Immunol (1993) 0.83
Transplantation antigens and viral carcinogenesis. Prog Med Virol (1969) 0.83
Platelet factor 4 binds to glycanated forms of thrombomodulin and to protein C. A potential mechanism for enhancing generation of activated protein C. J Biol Chem (1997) 0.83
Immunology of carcinogenesis. Cancer Res (1968) 0.82
Single breath CO2 analysis: description and validation of a method. Crit Care Med (1996) 0.82
Selection at multiple checkpoints focuses V(H)12 B cell differentiation toward a single B-1 cell specificity. J Exp Med (1999) 0.82
H-2 effects on cell-cell interactions in the response to single non-H-2 alloantigens. I. Donor H-2D region control of H-7.1-immunogenicity and lack of restriction in vivo. J Exp Med (1977) 0.82
Identification of a highly conserved module in E proteins required for in vivo helix-loop-helix dimerization. J Biol Chem (1998) 0.82
Models of B-cell unresponsiveness. Cold Spring Harb Symp Quant Biol (1989) 0.81
The murine male antigen. I. Sensitive detection by the PEC transfer system. Cell Immunol (1974) 0.81
Molecular analysis of skewed Tcra-V gene use in T-cell receptor beta-chain transgenic mice. Immunogenetics (1998) 0.81
Experimental globe rupture after excimer laser photorefractive keratectomy. Arch Ophthalmol (1995) 0.81
Signaling to a B-cell clone by Ek, but not Ak, does not reflect alteration of Ak genes. Immunogenetics (1988) 0.81
Early commitment to neoplasia in murine B- and T-cell lymphomas arising late in life. J Natl Cancer Inst (1989) 0.80
A simple method for the preparation of antisera specific for murine immunoglobulin heavy chains. J Immunol Methods (1978) 0.80
Noninvasive determination of cardiac output using single breath CO2 analysis. Crit Care Med (1996) 0.80
Infantile subconjunctival and anterior orbital fibrous histiocytoma. Ultrastructural and immunohistochemical studies. Ophthalmology (1988) 0.80
Intrasubunit homogeneity in heterogeneous IgM antibodies to the DNP moiety derived from a murine hybridoma cell line. Mol Immunol (1982) 0.80
Genetics, the immune response and oncogenesis. Transplant Rev (1976) 0.80
Development and characterization of three recombinant single chain antibody fragments (scFvs) directed against the CD19 antigen. Cancer Res (1995) 0.79